Quinta do Conde, Portugal

Márcio Temtem


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Márcio Temtem: Innovator in Pharmaceutical Technologies

Introduction

Márcio Temtem is a notable inventor based in Quinta do Conde, Portugal. He has made significant contributions to the field of pharmaceutical technologies, holding two patents that showcase his innovative approaches to complexation and particle manufacturing.

Latest Patents

His latest patents include a process for the continuous complexation of active pharmaceutical ingredients. This complexation process involves a cyclodextrin and active pharmaceutical ingredients, resulting in higher yields of complexation in less time compared to prior art methods. The complexes produced enhance the dissolution and bioavailability of the active pharmaceutical ingredients in body fluids. Another significant patent is for the continuous production of micro- and/or nanoparticles. This method allows for the continuous manufacture of single component or multi-component particles, including particulate amorphous solid dispersions and particulate co-crystals. The process involves several steps, including the preparation of solutions, microfluidization, filtration, and drying to obtain the desired particles.

Career Highlights

Márcio has worked with reputable companies such as Hovione Scientia Limited and Hovione Holding Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

He has collaborated with professionals like Tiago Fonseca and Iris Duarte, further enhancing his work in the field.

Conclusion

Márcio Temtem's contributions to pharmaceutical technologies through his patents reflect his commitment to innovation and improvement in the industry. His work continues to influence the development of more effective pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…